In this respect, the FDA???s restrictions on off-label promotion backfired on plaintiff ??? since only very limited promotion was permitted:[F]ederal law at the time relevant to this action explicitly permitted manufacturers to promote off-label uses of their devices by disseminating certain types of information about those off-label uses-and to do so without having to provide instructions or warn